1) On Apr 11, 2018 at 7:00 AM EDT Arrowhead pharma announced in their Clinical Data Results One HBeAg-negative patient serocleared HBsAg post ARC-520 (In the study, 8 chronic hepatitis patients (5 HBeAg-negative, 3 HBeAg-positive)
http://ir.arrowheadpharma.com/news-releases/news-release-details/arrowhead-pharmaceuticals-presents-arc-520-clinical-data
2) other side on March 14, 2018 ---Spring Bank Announces an impressive results on thier Combined Inarigivir 25 mg and 50 mg 12 and 24 Week clicnical trails.
http://ir.springbankpharm.com/news-releases/news-release-details/spring-bank-announces-presentation-combined-inarigivir-25-mg-and?field_nir_news_date_value[min]=2018
i hope we can get back our happiness & be like normal people if cure is near by .